ANNX Annexon, Inc.
Healthcare$5.52+3.95%ClosedMarket Cap: $660.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.04
P/S
0.00
EV/EBITDA
-2.43
DCF Value
$0.79
FCF Yield
-28.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-101.2%
ROA
-74.7%
ROIC
-89.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-46.1M | $-44.1M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-50.3M | $-48.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-216.4M | $-206.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-57.0M | $-54.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-51.7M | $-49.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-57.4M | $-54.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-52.5M | $-48.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-154.1M | $-138.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-39.4M | $-34.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-33.6M | $-29.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-28.6M | $-25.2M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-30.0M | $-27.9M | $-0.36 | — |